SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008693
Filing Date
2024-05-28
Accepted
2024-05-28 17:28:28
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scpx-20240331x10q.htm   iXBRL 10-Q 1486383
2 EX-31.1 scpx-20240331xex31d1.htm EX-31.1 26115
3 EX-31.2 scpx-20240331xex31d2.htm EX-31.2 27362
4 EX-32.1 scpx-20240331xex32d1.htm EX-32.1 11309
5 EX-32.2 scpx-20240331xex32d2.htm EX-32.2 13601
  Complete submission text file 0001558370-24-008693.txt   8462872

Data Files

Seq Description Document Type Size
6 EX-101.SCH scpx-20240331.xsd EX-101.SCH 69541
7 EX-101.CAL scpx-20240331_cal.xml EX-101.CAL 89116
8 EX-101.DEF scpx-20240331_def.xml EX-101.DEF 270831
9 EX-101.LAB scpx-20240331_lab.xml EX-101.LAB 626577
10 EX-101.PRE scpx-20240331_pre.xml EX-101.PRE 478557
84 EXTRACTED XBRL INSTANCE DOCUMENT scpx-20240331x10q_htm.xml XML 1392991
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 24993162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)